389 related articles for article (PubMed ID: 11514944)
21. Possible long-term teratogenic effect of isotretinoin in pregnancy.
Malvasi A; Tinelli A; Buia A; De Luca GF
Eur Rev Med Pharmacol Sci; 2009; 13(5):393-6. PubMed ID: 19961047
[TBL] [Abstract][Full Text] [Related]
22. Major auricular malformations due to Accutane (isotretinoin).
Jahn AF; Ganti K
Laryngoscope; 1987 Jul; 97(7 Pt 1):832-5. PubMed ID: 2955181
[TBL] [Abstract][Full Text] [Related]
23. Accutane risk management program strengthened.
FDA Consum; 2002; 36(1):8. PubMed ID: 11881607
[No Abstract] [Full Text] [Related]
24. Retinoic acid embryopathy.
Lammer EJ; Chen DT; Hoar RM; Agnish ND; Benke PJ; Braun JT; Curry CJ; Fernhoff PM; Grix AW; Lott IT
N Engl J Med; 1985 Oct; 313(14):837-41. PubMed ID: 3162101
[TBL] [Abstract][Full Text] [Related]
25. Isotretinoin use and compliance with the Dutch Pregnancy Prevention Programme: a retrospective cohort study in females of reproductive age using pharmacy dispensing data.
Teichert M; Visser LE; Dufour M; Rodenburg E; Straus SM; De Smet PA; Stricker BH
Drug Saf; 2010 Apr; 33(4):315-26. PubMed ID: 20297863
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy outcome following exposure to permethrin and use of teratogen information.
Kennedy D; Hurst V; Konradsdottir E; Einarson A
Am J Perinatol; 2005 Feb; 22(2):87-90. PubMed ID: 15731987
[TBL] [Abstract][Full Text] [Related]
27. Minor malformations characteristic of the retinoic acid embryopathy and other birth outcomes in children of women exposed to topical tretinoin during early pregnancy.
Loureiro KD; Kao KK; Jones KL; Alvarado S; Chavez C; Dick L; Felix R; Johnson D; Chambers CD
Am J Med Genet A; 2005 Jul; 136(2):117-21. PubMed ID: 15940677
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcomes during treatment with interferon beta-1a in patients with multiple sclerosis.
Sandberg-Wollheim M; Frank D; Goodwin TM; Giesser B; Lopez-Bresnahan M; Stam-Moraga M; Chang P; Francis GS
Neurology; 2005 Sep; 65(6):802-6. PubMed ID: 16093457
[TBL] [Abstract][Full Text] [Related]
29. Accutane (isotretinoin) revisited: severe birth defects from acne therapy.
Hansen RC
Ariz Med; 1985 Jun; 42(6):363-5. PubMed ID: 3161486
[No Abstract] [Full Text] [Related]
30. [Pregnancy after isotretinoin use].
Manders KC; de Vries LC; Roumen FJ
Ned Tijdschr Geneeskd; 2013; 157(41):A6567. PubMed ID: 24103139
[TBL] [Abstract][Full Text] [Related]
31. [Pregnancy outcome after ecstasy use; 43 cases followed by the Teratology Information Service of the National Institute for Public Health and Environment (RIVM)].
van Tonningen-van Driel MM; Garbis-Berkvens JM; Reuvers-Lodewijks WE
Ned Tijdschr Geneeskd; 1999 Jan; 143(1):27-31. PubMed ID: 10086095
[TBL] [Abstract][Full Text] [Related]
32. Safety issues in isotretinoin therapy.
Hanson N; Leachman S
Semin Cutan Med Surg; 2001 Sep; 20(3):166-83. PubMed ID: 11594672
[TBL] [Abstract][Full Text] [Related]
33. [Isotretinoin embryopathy. Report of one case].
Troncoso Sch M; Rojas H C; Bravo C E
Rev Med Chil; 2008 Jun; 136(6):763-6. PubMed ID: 18769834
[TBL] [Abstract][Full Text] [Related]
34. Dermatologists' level of compliance with the prescription guidelines of isotretinoin for females of childbearing potential.
AlGhamdi KM; Khurram H; Asiri YA; Mandil A
Int J Dermatol; 2011 Sep; 50(9):1094-8. PubMed ID: 22126870
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy outcome following first trimester exposure to chloroquine.
Levy M; Buskila D; Gladman DD; Urowitz MB; Koren G
Am J Perinatol; 1991 May; 8(3):174-8. PubMed ID: 2029276
[TBL] [Abstract][Full Text] [Related]
36. Prescriptions filled during pregnancy for drugs with the potential of fetal harm.
Kulaga S; Zargarzadeh AH; BĂ©rard A
BJOG; 2009 Dec; 116(13):1788-95. PubMed ID: 19832828
[TBL] [Abstract][Full Text] [Related]
37. Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999.
Stone KM; Reiff-Eldridge R; White AD; Cordero JF; Brown Z; Alexander ER; Andrews EB
Birth Defects Res A Clin Mol Teratol; 2004 Apr; 70(4):201-7. PubMed ID: 15108247
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy outcome post renal transplantation.
Sgro MD; Barozzino T; Mirghani HM; Sermer M; Moscato L; Akoury H; Koren G; Chitayat DA
Teratology; 2002 Jan; 65(1):5-9. PubMed ID: 11835226
[TBL] [Abstract][Full Text] [Related]
39. When a uniquely effective drug is teratogenic. The case of isotretinoin.
Stern RS
N Engl J Med; 1989 Apr; 320(15):1007-9. PubMed ID: 2522591
[No Abstract] [Full Text] [Related]
40. Who's heard of the Pregnancy Prevention Program?
Hatcher L
Can Fam Physician; 1999 Apr; 45():871-2. PubMed ID: 10216779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]